Most unaware of out-of-pocket costs for prostate cancer tx

January 5, 2013
Most unaware of out-of-pocket costs for prostate cancer tx
Most patients with localized prostate cancer know little about the out-of-pocket expenses of the different treatments, and would not have chosen a different treatment even if they had known the actual out-of-pocket expenses of their treatment, according to a study published in the December issue of Urology.

(HealthDay)—Most patients with localized prostate cancer know little about the out-of-pocket expenses (OOPE) of the different treatments, and would not have chosen a different treatment even if they had known the actual OOPE of their treatment, according to a study published in the December issue of Urology.

Olivia S. Jung, from Harvard Business School in Boston, and colleagues conducted a qualitative research study involving 41 patients with clinically localized prostate cancer enrolled from the and radiology practices of the University of Pennsylvania. Participants completed a semi-structured interview and questionnaire discussing the burden of OOPE, its effect on , and of OOPE.

Based on qualitative assessment, the researchers identified five major themes: "my insurance takes care of it;" "health is more important than cost;" "I did not look into it;" "I cannot afford it but would have chosen the same treatment;" and "it is not my doctor's business." Ninety-three percent of patients reported that, even if they had known the actual OOPE of their treatment, they would not have chosen a different treatment. A socioeconomically heterogeneous group reported feeling burdened by OOPE, and their choice of treatment was unaffected. Before choosing their treatment, only two of the patients reported knowing a lot about the likely OOPE for different treatments.

"Among insured patients with treated at a large academic medical center, few had knowledge of OOPE before making treatment choices," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Complementary medicine not tied to prostate cancer outcome

May 4, 2012

(HealthDay) -- Although widely used, complementary and alternative medicine (CAM) does not impact patient satisfaction with treatment or patient-reported outcomes after treatment for localized prostate cancer, according to ...

Recommended for you

New treatment options for a fatal leukemia

July 27, 2015

In industrialized countries like in Europe, acute lymphoblastic leukemia is the most common form of cancer in children. An international research consortium lead by pediatric oncologists from the Universities of Zurich and ...

Modified DNA building blocks are cancer's Achilles heel

July 22, 2015

In studying how cells recycle the building blocks of DNA, Ludwig Cancer Research scientists have discovered a potential therapeutic strategy for cancer. They found that normal cells have highly selective mechanisms to ensure ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.